5

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: February 9, 2018
Period of Report: December 31, 2017
Accession Number: 0001553878-18-000001

View Document ↗ View on SEC.gov ↗